3 assets in Bone Marrow Disorder

Therapeutic assets addressing Bone Marrow Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fludarabine Bone Marrow Disorder	Fred Hutchinson Cancer Center	P2	BB (68)
Cyclophosphamide Bone Marrow Disorder	Aileron Therapeutics, Inc.	P1	CC (43)
Allogeneic Human Umbilical Cord Blood Bone Marrow Disorder	Shandong Qilu Stem Cells Engineering Co., Ltd.	N/A	D (30)